Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
iX Biopharma Ltd. ( (SG:42C) ) has issued an update.
iX Biopharma Ltd. has entered into a placement agreement with Oversea-Chinese Banking Corporation Limited to raise a minimum of S$5,000,000 through the issuance of new ordinary shares. This strategic move aims to enhance the company’s capital structure by offering shares that will constitute approximately 5.33% of its enlarged share capital. The placement is structured as an exempt offering in Singapore, targeting institutional and accredited investors, and is expected to bolster the company’s financial position, potentially impacting its market operations and investor relations positively.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative therapies, with a particular emphasis on sublingual drug delivery systems.
Average Trading Volume: 8,678,119
Technical Sentiment Signal: Buy
Current Market Cap: S$83.55M
Learn more about 42C stock on TipRanks’ Stock Analysis page.